(Press-News.org) LIVERPOOL, UK – 9 May 2014: A University of Liverpool study of fruit flies has revealed that males forced to compete with other males become less attractive to females and die young.
In the test, male fruit flies of the species Drosophila subobscura were kept either alone or in groups. The females of this species are monandrous – they only mate once in their lives, meaning that males have to get very lucky to mate at all. As a result males compete furiously for access to females.
Evolutionary biologist, Dr Anne Lizé, who led the study said: "When we see stags fighting over mates, it's obvious what the potential costs to the males are, but in this case it's more subtle. The flies aren't using antlers to beat each other into submission, but instead are harassing each other to the point where exhaustion causes them to die young."
Dr Lizé and her colleagues from the University's Institute of Integrative Biology, think that rivals disrupt the flies' sleep patterns, which has already been identified as a cause of early death in many other species, and is potentially harmful to humans.
Males exposed to rivals fare even worse when they finally do meet a virgin female. Females strongly prefer the males that were kept alone, with females refusing to mate with three quarters of the males that previously had to battle with rivals.
Dr Lizé concluded: "The idea that competition has more subtle effects on a male could be extended to other species that humans are trying to breed or keep healthy."
INFORMATION:
The study was funded by the Natural Environment Research Council (NERC) and published in Proceedings of the Royal Society B.
Shorter lives for male fruit flies forced to compete
2014-05-19
ELSE PRESS RELEASES FROM THIS DATE:
One small chip -- one giant leap forward for early cancer detection
2014-05-19
Today, the majority of cancers are detected on the macroscopic level, when the tumor is already composed of millions of cancer cells and the disease is starting to advance into a more mature phase. But what if we could diagnose cancer before it took hold- while it was still only affecting a few localized cells? It would be like putting a fire out while it was still just a few sparks versus after having already caught on and spread to many areas of the house.
An international team of researchers, led by ICFO- Institute of Photonic Sciences in Castelldefels, announce ...
Study finds limited benefit for vitamin D in asthma treatment
2014-05-19
Adding vitamin D to asthma treatment to improve breathing only appears to benefit patients who achieve sufficient levels of the supplement in the blood. Overall, the ability to control asthma did not differ between a study group that received vitamin D supplements and a group that received placebo, according to new research at Washington University School of Medicine in St. Louis.
"Previous studies suggested that if you have asthma and low levels of vitamin D in the blood, you have worse lung function, more asthma attacks and more emergency room visits than asthma patients ...
Illuminating neuron activity in 3-D
2014-05-18
Researchers at MIT and the University of Vienna have created an imaging system that reveals neural activity throughout the brains of living animals. This technique, the first that can generate 3-D movies of entire brains at the millisecond timescale, could help scientists discover how neuronal networks process sensory information and generate behavior.
The team used the new system to simultaneously image the activity of every neuron in the worm Caenorhabditis elegans, as well as the entire brain of a zebrafish larva, offering a more complete picture of nervous system ...
Team validates potentially powerful new way to treat HER2-positive breast cancer
2014-05-18
Cold Spring Harbor, NY -- Scientists at Cold Spring Harbor Laboratory (CSHL) today report a discovery that they hope will lead to the development of a powerful new way of treating an aggressive form of breast cancer.
The breast cancer subtype in question is commonly called "HER2-positive"; it's a subset of the disease affecting about one patient in four, in which tumor cells overexpress a signaling protein called HER2. The blockbuster drug Herceptin is a treatment of choice for many women with HER2-positive breast cancer, but in most cases, resistance to the treatment ...
COPD patients at significantly higher risk of heart failure
2014-05-18
ATS 2014, SAN DIEGO ─ As if increased risks of high blood pressure, respiratory infections, lung cancer and even depression weren't enough, researchers say patients with chronic obstructive pulmonary disease (COPD) have another complication to worry about: heart failure. That's according to a new study from the Morehouse School of Medicine in Atlanta, which found the prevalence of heart failure is significantly higher in patients with COPD compared to the rest of the study population. They also found that the risk was especially high among African-American patients ...
Patients with low pulmonary vascular resistance may benefit from complex procedure for PH
2014-05-18
ATS 2014, SAN DIEGO ─ Patients with chronic pulmonary thromboembolic disease may benefit from pulmonary thromboendarterectomy (PTE), even if the patients don't have severe pulmonary hypertension, according to University of California, San Diego, researchers.
The study was presented at the 2014 American Thoracic Society International Conference.
UCSD pioneered PTE in the 1970s for patients who suffered from chronic thromboembolic pulmonary hypertension (CTEPH). During PTE, surgeons put a patient on a heart-lung machine, cool the body to reduce its need for oxygen ...
Urine test could help clinicians spot blood clots in at-risk patients
2014-05-18
ATS 2014, SAN DIEGO ─ A new study by researchers from California and Canada indicates a simple urine test can indicate the presence of venous thromboembolism, a blood clot that has broken free from its point of origin and which travels through the bloodstream, eventually lodging in a vein. The test evaluates the levels of fibrinopeptide B (FPB), a small peptide that's released when a thrombosis forms and which is removed from the body through urine.
The results of the study will be presented at the American Thoracic Society's 2014 International Conference here.
Study ...
Sleep apnea is common after acute respiratory failure
2014-05-18
ATS 2014, SAN DIEGO ─ Clinically important sleep apnea is common among survivors of acute respiratory failure, according to a new study presented at the 2014 American Thoracic Society International Conference.
"Insomnia is a frequent complaint among survivors of critical illness," said Dr. Elizabeth Parsons, MD, MSc, of the Division of Pulmonary & Critical Care Medicine at the University of Washington in Seattle. "We examined a small cohort of survivors of acute respiratory failure to understand modifiable contributors to insomnia, including sleep apnea."
The ...
Bacteria in mouth may diagnose pancreatic cancer
2014-05-18
Patients with pancreatic cancer have a different and distinct profile of specific bacteria in their saliva compared to healthy controls and even patients with other cancers or pancreatic diseases, according to research presented today at the annual meeting of the American Society for Microbiology. These findings could form the basis for a test to diagnose the disease in its early stages.
"Our studies suggest that ratios of particular types of bacteria found in saliva may be indicative of pancreatic cancer," says Pedro Torres of San Diego State University who presented ...
Temple-led study finds no benefit in taking statin drugs for COPD exacerbation prevention
2014-05-18
(Philadelphia, PA) – A statin drug commonly used to lower cholesterol is not effective in reducing the number and severity of flare ups from chronic obstructive pulmonary disease (COPD), according to the results of a large multicenter clinical trial designed and directed by Gerard J. Criner, MD, Director of Pulmonary and Critical Care Medicine at Temple University Hospital in Philadelphia, PA.
Dr. Criner, who served as the study's Principal Investigator, will report the results on May 18 at the American Thoracic Society's annual international scientific meeting in San ...